Literature DB >> 18683503

Ex vivo production of interferon-gamma, tumor necrosis factor-alpha, and interleukin-6 by mouse macrophages during infection with M. bovis and M. tuberculosis H37Rv.

L N Chernousova1, T G Smirnova, E G Afanasieva, V L Karpov, A V Timofeev.   

Abstract

Ex vivo production of IFN-gamma, TNF-alpha, and IL-6 by mouse peritoneal macrophages was studied during successive infection with the vaccine strain M. bovis BCG and virulent strain M. tuberculosis H37Rv. The increase in the concentrations of TNF-alpha and IL-6 did not depend on the sequence of macrophage infection with the vaccine or virulent strain, but was related to the presence of the vaccine strain M. bovis BCG in the medium. IFN-gamma production depended on infection of macrophages with the virulent strain M. tuberculosis H37Rv. The concentration of IFN-gamma was maximum during primary infection with the virulent strain and did not increase after successive infection with the virulent and vaccine strain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18683503     DOI: 10.1007/s10517-007-0412-4

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  Preventive effects of mycobacteria and their culture supernatants against asthma development in BALB/c mice.

Authors:  Eui-Ryoung Han; Inseon S Choi; Sun-Ho Eom; Hwa-Jung Kim
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

2.  Therapeutic effects of mycobacterial secretory proteins against established asthma in BALB/c mice.

Authors:  Eui-Ryoung Han; Inseon S Choi; Han-Gyu Choi; Hwa-Jung Kim
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-19       Impact factor: 5.764

3.  De novo histidine biosynthesis protects Mycobacterium tuberculosis from host IFN-γ mediated histidine starvation.

Authors:  Abhisek Dwivedy; Anam Ashraf; Bhavya Jha; Deepak Kumar; Nisheeth Agarwal; Bichitra K Biswal
Journal:  Commun Biol       Date:  2021-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.